Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jparsons
    Member
    • Feb 2012
    • 62

    #1

    Checking Cuffdiff

    I am using an interesting dataset to "test" differential isoform expression programs.

    Unfortunately, I am not an expert in every (any?) program, so I could use some sanity checking.

    I have 3 separate tissues, ABC. I want to use (in this case) cuffdiff to identify isoforms which are uniquely expressed in A/B/C, as I can use other "ground truth" runs to verify these claims.

    I ran the program as follows, alternating A, B, and C:
    Code:
     cuffdiff -p 8 -c 10 <ucsc.gtf> A1,A2,A3 B1,B2,B3,C1,C2,C3 -o outdir
    I'm not using a cufflinks-derived gtf or (exclusively) tophat-mapped reads. I imagine I'm doing it all wrong. I have two main questions:

    1) Can I get away with not using the entire cufflinks pathway here? (If not, why doesn't the program complain?)
    2) Am I properly comparing the 3 tissues? Does A vs B,C return transcripts DE in only A, as i intend it to?
  • rboettcher
    Member
    • Oct 2010
    • 71

    #2
    Hello jparsons,

    I used cufflinks and cuffdiff with GSNAP alignments and it worked fine, so you do not need to stick to TopHat necessarily as long as the sam/bam-files have all required columns.
    However, I used the cufflinks -> cuffmerge -> cuffdiff variant to check my genes, since that way was suggested by the authors (but not very successful for me).

    After following some discussions in this forum, see
    http://seqanswers.com/forums/showthread.php?t=20702
    and
    http://seqanswers.com/forums/showthread.php?t=16528

    I concluded that cufflinks/cuffdiff have a problem in their correction for variance. For my analysis, the bigger my sample groups were, the fewer genes were found significantly DE until none were left. Therefore I assume that pooling group B and C will result in a similar problem due to high variance between both groups.

    Besides that, your command looks fine, so please keep us posted on your progress.

    Comment

    • jparsons
      Member
      • Feb 2012
      • 62

      #3
      Rboettcher,

      Thanks for the response. I eventually compared the output from tophat->cufflinks->cuffmerge->cuffdiff to that from only cuffdiff and found that they were (mostly) identical. I am content using cuffdiff without going through the entire pipeline.

      I got results for cuffdiff and finally managed to get RSEM to like me for long enough to spit out quantitations. When compared to the "truth" set (sadly only available on the gene level for now), the RSEM/cuffdiff lists are 'decent' individually, coming close to the expected ratio on average, but having numerous outliers. Taking the overlap set of genes called by both RSEM and cuffdiff makes for a much cleaner picture, with far less deviation from the ratio, and fewer false positives.

      I'm still working on making metrics that make sense, so 'decent' and 'cleaner' is the best i can offer for now. I imagine I will develop permissive and restrictive "true positive" lists at each ratio and then generate ROCs for each algorithm I can successfully test.

      I'm currently worried about algorithms making calls for downregulated genes or calling them as differentially expressed in cases where the assumption that "A>>B+C or A<<B+C" doesn't hold. I don't know how to handle that yet, and it may be the source of the outliers I mentioned before.

      Overall, I am actually impressed with cuffdiff's performance, given how much grief it gets here. Neither algorithm is even remotely perfect, neither is obviously superior.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...